Coronavirus Update: Pfizer CEO Thinks Vaccine Price Rise Likely Post-Pandemic
Plus: SinoVac Results Disappoint, AstraZeneca Files in EU
Executive Summary
Companies will raise their COVID-19 vaccine prices once the pandemic is over – but key long-term data will determine which comes out on top.